Advertisement

Venus Remedies posted loss of Rs.9.62 millions in (Q3) FY 2019-20

Source: 
Team Infinities:

Venus Remedies Limited NSE Symbol:VENUSREM, BSE Security Code:526953 has declared its 3rd(third) quarter un-audited Consolidated financial report from the month of October, 2019 to the month of December, 2019; for the fiscal year 2019-20.

Revenue Reported by Venus Remedies Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
986.32 892.39 788.71 2623.40 2359.22
Calculated Revenue of Venus Remedies Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
93.93 10.53%(Revenue Increase) 197.61 25.05%(Revenue Increase) 264.18 11.20%(Revenue Increase)

Revenue: Venus Remedies Limited's financial report shows that the company's revenue increased by 10.53% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for revenue increase of Rs.93.93 millions, as the company posted revenue of Rs.986.32 millions; in compare to previous quarter(July, 2019 - September, 2019) when the company reported revenue of Rs.892.39 millions.
The result also shows that the company's revenue increased by 25.05% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for revenue increase of Rs.197.61 millions; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted revenue of Rs.788.71 millions.
The company also reported that its revenue increased by 11.20% in 9 months end(April, 2019 - December, 2019) for revenue increase of Rs.264.18 millions, since the company reported revenue of Rs.2623.40 millions; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted revenue of Rs.2359.22 millions.

Gross Margin(%) Reported by Venus Remedies Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
28.30 51.56 41.10 45.06 39.98
Calculated Gross Margin(%) of Venus Remedies Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
23.26 45.11%(GM Decrease) 12.80 31.15%(GM Decrease) 5.08 12.71%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM decreased by 45.11% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for 23.26% GM decrease, as the company reported 28.30% GM; in compare to previous quarter(July, 2019 - September, 2019) when the company reported 51.56% GM.
The result also indicates, the company's GM decreased by 31.15% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for 12.80% GM decrease; in compare to corresponding quarter(October, 2018 - December, 2018) when the company reported 41.10% GM.
The company also reported that its GM increased by 12.71% in 9 months end(April, 2019 - December, 2019) for 5.08% GM increase, since the company reported 45.06% GM; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company reported 39.98% GM.

EBITDA Reported by Venus Remedies Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
125.67 140.52 63.48 372.25 366.08
Calculated EBITDA of Venus Remedies Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
14.85 10.57%(EBITDA Decrease) 62.19 97.97%(EBITDA Increase) 6.17 1.69%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 10.57% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EBITDA decrease of Rs.14.85 millions, as the company posted EBITDA of Rs.125.67 millions; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EBITDA of Rs.140.52 millions.
The result also shows that the company's EBITDA increased by 97.97% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EBITDA increase of Rs.62.19 millions; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted EBITDA of Rs.63.48 millions.
The company also reported that its EBITDA increased by 1.69% in 9 months end(April, 2019 - December, 2019) for EBITDA increase of Rs.6.17 millions, since the company reported EBITDA of Rs.372.25 millions; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted EBITDA of Rs.366.08 millions.

Profit and Loss Reported by Venus Remedies Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
9.62(Loss ) 4.16(Profit ) 117.30(Loss ) 46.19(Loss ) 171.10(Loss )
Calculated Profit and Loss of Venus Remedies Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
13.78 331.25%(Loss Increase) 107.68 91.80%(Loss Decrease) 124.91 73.00%(Loss Decrease)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's loss increased by 331.25% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for loss increase of Rs.13.78 millions, as the company posted loss of Rs.9.62 millions; in compare to previous quarter(July, 2019 - September, 2019) when the company reported profit of Rs.4.16 millions.
The result also shows that the company's loss decreased by 91.80% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for loss decrease of Rs.107.68 millions; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted loss of Rs.117.30 millions.
The company also reported that its loss decreased by 73.00% in 9 months end(April, 2019 - December, 2019) for loss decrease of Rs.124.91 millions, since the company reported loss of Rs.46.19 millions; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted loss of Rs.171.10 millions.

EPS Reported by Venus Remedies Limited for Third Quarter FY, 2019-20
Current Quarter (October, 2019 - December, 2019) Previous Quarter (July, 2019 - September, 2019) Corresponding Quarter (October, 2018 - December, 2018) 9 Months Ended (April, 2019 - December, 2019) Corresponding 9 Months Ended (April, 2018 - December, 2018)
0.78(Negative) 0.34 9.50(Negative) 3.74(Negative) 13.86(Negative)
Calculated EPS of Venus Remedies Limited for Third Quarter FY, 2019-20
Current(December, 2019) VS Previous(September, 2019) Current(December, 2019) VS Corresponding(December, 2018) 9 months Ended(April, 2019 - December, 2019) VS Corresponding 9 months Ended(April, 2018 - December, 2018)
Change Change % Change Change % Change Change %
1.12 329.41%(EPS Decrease) 8.72 91.79%(EPS Increase) 10.12 73.02%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 329.41% in QoQ(Quarter on Quarter) / current quarter(October, 2019 - December, 2019) for EPS decrease of Rs.1.12, as the company posted Negative EPS of Rs.0.78; in compare to previous quarter(July, 2019 - September, 2019) when the company reported EPS of Rs.0.34.
The result also shows that the company's EPS increased by 91.79% in YoY(Year over Year) / in current quarter(October, 2019 - December, 2019) for EPS increase of Rs.8.72; in compare to corresponding quarter(October, 2018 - December, 2018) when the company posted Negative EPS of Rs.9.50.
The company also reported that its EPS increased by 73.02% in 9 months end(April, 2019 - December, 2019) for EPS increase of Rs.10.12, since the company reported Negative EPS of Rs.3.74; in compare to corresponding 9 months end(April, 2018 - December. 2018) when the company posted Negative EPS of Rs.13.86.



***All amounts are given in Million Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

Add new comment

Comment Editor

  • No HTML tags allowed.
CAPTCHA
Please verify you are a human